has been associated to increased resource consumption. In turn, pregnancy has been associated with an increased risk of developing primary viral pneumonia. 10 In the 2011 epidemic, hematological disease, general seriousness, infiltrations on the chest X-rays and the need for MV were the variables independently correlated to mortality. 2 The SEMICYUC developed a series of management recommendations during the pandemic phase. 11 
Likewise, the European Respiratory Society and the European Society of Intensive Care Medicine
12 recommend the avoidance of NIV and the intubation of patients infected with the new H1N1 virus admitted to the Intensive Care Unit with severe hypoxemia, rapidly developing ARDS, multiorgan failure and refractory hypoxia. In the absence of these conditions, NIV only should be considered in patients with moderate hypercapnic acute respiratory alterations secondary to exacerbation of a chronic respiratory disorder, acute respiratory failure secondary to acute lung edema, and post-extubation respiratory failure after ARDS secondary to H1N1 viral infection.
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During the pandemic, the use of NIV was reported in 25---45% of the patients, with a 75% failure rate. 13---15 The cases that failed showed higher scores on the severity scales, and possibly required intubation from the start. 13 In the first epidemic of 2010---2011, the no. 16 with improvement of the pandemic results probably as a result of adoption of the measures learned from the experience gained ---the data being similar to those recorded in metaanalyses analyzing NIV use in patients with ARDS / acute lung injury. 17 NIV has been successfully used in patients with acute respiratory failure secondary to acute lung edema, and in hypercapnic acute respiratory failure (level of evidence IA). However, its application in hypoxemic acute respiratory failure is subject to controversy, and the clinician in such situations must individualize each case. A relative contraindication to NIV in hypoxemic acute respiratory failure is the presence of P0 2 /Fi0 2 < 100. 18 However, of the patients included in the registry of Belenguer et al. 19 with P0 2 /Fi0 2 at admission, 87 presented parameters indicative of a good prognosis in the first hour, as defined in the literature. 18 The presented series even reported a poorer prognosis for coinfection together with the viral pneumonia 7 ---a circumstance not found in the series of Belenguer et al. 19 The good results reported by Belenguer et al. 19 can be explained by: (1) exclusive respiratory involvement, with no dysfunction of other organs ---this associating low APACHE II and SOFA scores, together with the absence of background disease and coinfection; (2) team experience described 20---23 as crucial for the success of NIV; and (3) rigorous isolation following the recommendations of the SEMICYUC 11 and the local Department of Preventive Medicine.
Experience added to the evidence possibly can contribute to define those patients who may benefit from less aggressive strategies for resolving the process. NIV during hypoxemic acute respiratory failure secondary to acute pneumonia caused by the H1N1 virus should be limited to highly selected patients, and always should be managed by teams with great experience, with the support of all the available treatment measures that are considered to be effective.
